Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California

Cancer Causes and Control

Volumn 19, Issue 8, 2008, Pages 887-894

  Parikh Patel, Arti ^a   White, Richard H ^b   Allen, Mark ^a   Cress, Rosemary ^a,b  

^a PUBLIC HEALTH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune diseases; Cancer; Hematologic neoplasms; Malignancy; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER RISK; FEMALE; HUMAN; INCIDENCE; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID CANCER; UNITED STATES; VAGINA CANCER; VULVA CANCER;

ADULT; CALIFORNIA; COHORT STUDIES; ETHNIC GROUPS; FEMALE; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 52449090815     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-008-9151-8     Document Type: Article

References (59)

1. Abu-Shakra M, Buskila D, Shoenfeld Y (2000) SLE and cancer. In: Shoenfeld Y, Gershwin ME (eds) Cancer and autoimmunity. Elsevier Science, pp 31-40
2. M Abu-Shakra DD Gladman MB Urowitz 2004 Mortality studies in SLE: how far can we improve survival of patients with SLE Autoimmun Rev 3 418 420
3. C Stahl-Hallengren A Jonsen O Nived G Sturfelt 2000 Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis J Rheumatol 27 685 691
4. MB Urowitz DD Gladman 2000 How to improve morbidity and mortality in systemic lupus erythematosus Rheumatology (Oxford) 39 238 244
5. MB Urowitz DD Gladman M Abu-Shakra VT Farewell 1997 Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years J Rheumatol 24 1061 1065
6. S Bernatsky JF Boivin L Joseph 2005 An international cohort study of cancer in systemic lupus erythematosus Arthritis Rheum 52 1481 1490
7. S Bernatsky R Ramsey-Goldman R Rajan 2005 Non-Hodgkin's lymphoma in systemic lupus erythematosus Ann Rheum Dis 64 1507 1509
8. L Bjornadal B Lofstrom L Yin IE Lundberg A Ekbom 2002 Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus Scand J Rheumatol 31 66 71
9. L Mellemkjaer V Andersen MS Linet G Gridley R Hoover JH Olsen 1997 Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus Arthritis Rheum 40 761 768
10. T Pettersson E Pukkala L Teppo C Friman 1992 Increased risk of cancer in patients with systemic lupus erythematosus Ann Rheum Dis 51 437 439
11. O Ragnarsson G Grondal K Steinsson 2003 Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus Lupus 12 687 691
12. Y Xu PH Wiernik 2001 Systemic lupus erythematosus and B-cell hematologic neoplasm Lupus 10 841 850
13. E Zintzaras M Voulgarelis HM Moutsopoulos 2005 The risk of lymphoma development in autoimmune diseases: a meta-analysis Arch Intern Med 165 2337 2344
14. R Ramsey-Goldman SA Mattai E Schilling 1998 Increased risk of malignancy in patients with systemic lupus erythematosus J Investig Med 46 217 222
15. DM Sweeney S Manzi J Janosky 1995 Risk of malignancy in women with systemic lupus erythematosus J Rheumatol 22 1478 1482
16. LJ Kinlen 1992 Malignancy in autoimmune diseases J Autoimmun 5 Suppl A 363 371
17. S Bernatsky A Clarke R Ramsey-Goldman 2002 Malignancy and systemic lupus erythematosus Curr Rheumatol Rep 4 351 358
18. SH Oertel H Riess 2002 Immunosurveillance, immunodeficiency and lymphoproliferations Recent Results Cancer Res 159 1 8
19. R Bhalla HS Ajmani WW Kim WI Swedler MB Lazarevic JL Skosey 1993 Systemic lupus erythematosus and Hodgkin's lymphoma J Rheumatol 20 1316 1320
20. KA Black PJ Zilko RL Dawkins BK Armstrong GL Mastaglia 1982 Cancer in connective tissue disease Arthritis Rheum 25 1130 1133
21. JJ Canoso AS Cohen 1974 Malignancy in a series of 70 patients with systemic lupus erythematosus Arthritis Rheum 17 383 390
22. JA Green AA Dawson W Walker 1978 Systemic lupus erythematosus and lymphoma Lancet 2 753 756
23. M Abu-Shakra DD Gladman MB Urowitz 1996 Malignancy in systemic lupus erythematosus Arthritis Rheum 39 1050 1054
24. J Cibere J Sibley M Haga 2001 Systemic lupus erythematosus and the risk of malignancy Lupus 10 394 400
25. O Nived A Bengtsson A Jonsen G Sturfelt H Olsson 2001 Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden Lupus 10 500 504
26. SM Sultan Y Ioannou DA Isenberg 2000 Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review Rheumatology (Oxford) 39 1147 1152
27. Services USDoHaH (2000) ICD-9-CM: international classification of diseases, 9th Revision, Clinical modification, 6th edition, Washington DC
28. Cancer Reporting in California (1997) Standards for automated reporting. California cancer reporting system standards, vol II. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA, December 1997
29. Cancer Reporting in California (1997) Data standards for regional registries and California Cancer Registry. California cancer reporting system standards, vol III. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA, December 1997
30. Cancer Reporting in California (1998) Reporting procedures for physicians. California cancer reporting system standards, vol IV. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA, January 1998
31. Cancer Reporting in California (1997) Abstracting and coding procedures for hospitals. California cancer reporting system standards, vol I. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA, June 1997
32. Chen VW, Howe HL, Wu XC (2000) Cancer in North America, 1993-1997. Volume I: incidence. North American Association of Central Cancer Registries, Springfield
33. JE Seiffert WT Price B Gordon 1990 The California tumor registry: a state-of-the-art model for a regionalized, automated, population-based registry Top Health Rec Manage 11 59 73
34. Integrity Program (1999) Data reengineering environment software. Vality Technology Inc., Boston
35. Allen M (2001) Validation of OSHPD and CCR insurance status. California Association of Central Cancer Registries Technical Conference, Riverside, CA
36. Fritz A, Percy C, Jack A et al (2000) International classification of diseases for oncology, 3rd edn. World Health Organization, Geneva
37. Breslow NE, Day NE (1987) Statistical methods in cancer research, Volume II: the design and analysis of cohort studies. International Agency for Research on Cancer, Lyon
38. S Bernatsky JF Boivin L Joseph 2002 Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity J Rheumatol 29 2551 2554
39. IN Bruce DD Gladman MB Urowitz 1998 Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: a quality improvement study Clin Exp Rheumatol 16 435 440
40. T McAlindon L Giannotta N Taub D D'Cruz G Hughes 1993 Environmental factors predicting nephritis in systemic lupus erythematosus Ann Rheum Dis 52 720 724
41. M Petri S Perez-Gutthann D Spence MC Hochberg 1992 Risk factors for coronary artery disease in patients with systemic lupus erythematosus Am J Med 93 513 519
42. P Rahman MB Urowitz DD Gladman IN Bruce J Genest Jr 1999 Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus J Rheumatol 26 2363 2368
43. MM Ahmed SM Berney RE Wolf 2006 Prevalence of active hepatitis C virus infection in patients with systemic lupus erythematosus Am J Med Sci 331 252 256
44. S Berthier C Mougin P Vercherin 1999 Does a particular risk associated with papillomavirus infections exist in women with lupus? Rev Med Interne 20 128 132
45. LS Tam AY Chan PK Chan AR Chang EK Li 2004 Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection Arthritis Rheum 50 3619 3625
46. RH Thomas CM Ridley MM Black 1985 Lichen sclerosus et atrophicus associated with systemic lupus erythematosus J Am Acad Dermatol 13 832 833
47. RB Gibbons E Westerman 1988 Acute nonlymphocytic leukemia following short-term, intermittent, intravenous cyclophosphamide treatment of lupus nephritis Arthritis Rheum 31 1552 1554
48. M Lishner G Hawker D Amato 1990 Chronic lymphocytic leukemia in a patient with systemic lupus erythematosus Acta Haematol 84 38 39
49. NS Rosenthal DC Farhi 1996 Myelodysplastic syndromes and acute myeloid leukemia in connective tissue disease after single-agent chemotherapy Am J Clin Pathol 106 676 679
50. S Vasquez AF Kavanaugh NR Schneider MC Wacholtz PE Lipsky 1992 Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents J Rheumatol 19 1625 1627
51. RW Elliott DM Essenhigh AR Morley 1982 Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit Br Med J (Clin Res Ed) 284 1160 1161
52. A Ortiz E Gonzalez-Parra G Alvarez-Costa J Egido 1992 Bladder cancer after cyclophosphamide therapy for lupus nephritis Nephron 60 378 379
53. JB Thrasher GJ Miller JN Wettlaufer 1990 Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis J Urol 143 119 121
54. S Bernatsky JF Boivin L Joseph 2005 Race/ethnicity and cancer occurrence in systemic lupus erythematosus Arthritis Rheum 53 781 784
55. GS Alarcon J Calvo-Alen G McGwin et al 2006 Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time Ann Rheum Dis 65 9 1168 1174
56. SR Bernatsky GS Cooper C Mill R Ramsey-Goldman AE Clarke CA Pineau 2006 Cancer screening in patients with systemic lupus erythematosus J Rheumatol 33 45 49
57. JN Katz J Barrett MH Liang 1997 Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures Arthritis Rheum 40 1594 1600
58. B Löfström C Backlin C Sundström A Ekbom IE Lundberg 2007 A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study Ann Rheum Dis 66 12 1627 1632
59. MC Hochberg 1997 Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 40 1725